tirzepatide cardiovascular outcomes trial results july 2025 compared with semaglutide and 10-year disease risk reduction in obesity: post-hoc analysis of the SURMOUNT-5 Designing Next-Generation Cardiometabolic Outcome Trials

The test identifies your genetic variants in GLP1R and GIPRthe exact receptors tirzepatide targetsplus fourteen other metabolic pathways to predict your personalized response

By promoting satiety and reducing food intake, semaglutide supports weight loss efforts by creating a calorie deficit

Pi-Sunyer X, Astrup A, Fujioka K, et al

Collagen peptides are an exception that have been on the market for a while now, with potential benefits including improvements in body recomposition and skin aging.17 18 Maximus offers two kinds of peptides: Sermorelin: a human growth hormone secretagogue capable of improving strength and muscle size while burning fat, and19 GLP-1 receptor agonists: the generic versions of things like Ozempic (semaglutide) and Mounjaro (tirzepatide), primarily targeting body fat and blood glucose.20 Between the two, sermorelin is the more novel treatment, and its a little more expensive